The latest financial statement is for the year ending 2025-12-31.
| Cash Flow | 2025-12-31 |
|---|---|
| Net income | 17,541 |
| Provision credit losses | 8,247 |
| Depreciation | 476 |
| Accretion, net | 2,063 |
| Deferred income tax (benefit) expense | -186 |
| Net loss on sale of equity security | -103 |
| Originations of loans held for sale | 49,749 |
| Proceeds from sale of loans held for sale | 47,477 |
| Net gains on sales of residential mortgage loans | 716 |
| Net losses (gains) on sales of commercial loans | -18 |
| Loss on disposal of premises and equipment | 0 |
| Loss on sale of other assets held for sale | 0 |
| Earnings on bank owned life insurance | 933 |
| Restricted stock expense, net of forfeitures | 1,394 |
| Accrued interest receivable and other assets | -1,474 |
| Operating lease right-of-use asset | 661 |
| Operating lease liability | 605 |
| Accrued interest payable and other liabilities | -4,451 |
| Net cash from operating activities | 18,688 |
| Available-for-sale securities maturities, prepayments and calls | 1,000 |
| Available-for-sale securities, purchases | 9,216 |
| Proceeds from the sale of equity security | 4,897 |
| Loan and lease originations and payments, net | 33,305 |
| Purchase of loans and leases | 9,935 |
| Proceeds from the sale of loans | 20,441 |
| Additions to premises and equipment | 487 |
| Redemption (purchase) of frb and fhlb stock | -564 |
| Purchase of other investments | 0 |
| Other adjustments | -477 |
| Proceeds from the sale of foreclosed assets | 524 |
| Proceeds from the sale of assets held for sale | 0 |
| Net cash used by investing activities | -25,040 |
| Net change in deposits | 24,894 |
| Proceeds from fhlb advances and other debt | 10,205 |
| Repayments on fhlb advances and other debt | 1,954 |
| Net change in advances by borrowers for taxes and insurance | 285 |
| Cash dividends paid | 1,948 |
| Proceeds from exercise of stock options | 0 |
| Acquisition of treasury shares surrendered upon vesting of restricted stock and exercised options for payment of taxes and exercise proceeds | 147 |
| Purchase of treasury shares | 1,283 |
| Net cash from (used by) financing activities | 30,052 |
| Net change in cash and cash equivalents | 23,700 |
| Beginning cash and cash equivalents | 235,272 |
| Ending cash and cash equivalents | 258,972 |
CF BANKSHARES INC. (CFBK)
CF BANKSHARES INC. (CFBK)